{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T04:37:42Z","timestamp":1683261462825},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00292-023-01186-5","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T10:03:22Z","timestamp":1682330602000},"page":"154-165","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Klassifikation indolenter B-Zell-Lymphome","Classification of indolent B-cell lymphomas"],"prefix":"10.1007","volume":"44","author":[{"given":"Ioannis","family":"Anagnostopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Zam\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"1186_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio\u00a0R, Amador\u00a0C, Anagnostopoulos\u00a0I et\u00a0al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"1186_CR2","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1182\/blood-2015-11-624312","volume":"127","author":"L Arcaini","year":"2016","unstructured":"Arcaini\u00a0L, Rossi\u00a0D, Paulli\u00a0M (2016) Splenic marginal zone lymphoma: from genetics to management. Blood 127:2072\u20132081","journal-title":"Blood"},{"key":"1186_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","volume":"131","author":"SM Aukema","year":"2018","unstructured":"Aukema\u00a0SM, Hoster\u00a0E, Rosenwald\u00a0A et al (2018) Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. Blood 131:417\u2013420","journal-title":"Blood"},{"key":"1186_CR4","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo\u00a0E, Jaffe\u00a0ES, Cook\u00a0JR et\u00a0al (2022) The international consensus classification of mature lymphoid neoplasms: a\u00a0report from the clinical advisory committee. Blood 140:1229\u20131253","journal-title":"Blood"},{"key":"1186_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3109\/10428194.2015.1096357","volume":"57","author":"X Cao","year":"2016","unstructured":"Cao\u00a0X, Medeiros\u00a0LJ, Xia\u00a0Y et\u00a0al (2016) Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression. Leuk Lymphoma 57:1104\u20131113","journal-title":"Leuk Lymphoma"},{"key":"1186_CR6","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1080\/10428194.2020.1719100","volume":"61","author":"JJ Castillo","year":"2020","unstructured":"Castillo\u00a0JJ, Itchaki\u00a0G, Gustine\u00a0JN et al (2020) A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia. Leuk Lymphoma 61:1388\u20131394","journal-title":"Leuk Lymphoma"},{"key":"1186_CR7","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1093\/annonc\/mdv375","volume":"26","author":"C Casulo","year":"2015","unstructured":"Casulo\u00a0C, Day\u00a0B, Dawson\u00a0KL et\u00a0al (2015) Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40\u00a0years of age and younger: an analysis from the National Lymphocare Studydagger. Ann Oncol 26:2311\u20132317","journal-title":"Ann Oncol"},{"key":"1186_CR8","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood.2022015854","volume":"140","author":"L De Leval","year":"2022","unstructured":"De Leval\u00a0L, Alizadeh\u00a0AA, Bergsagel\u00a0PL et\u00a0al (2022) Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140:2193\u20132227","journal-title":"Blood"},{"key":"1186_CR9","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.3324\/haematol.2019.237073","volume":"105","author":"C Fuster","year":"2020","unstructured":"Fuster\u00a0C, Martin-Garcia\u00a0D, Balague\u00a0O et al (2020) Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma. Haematologica 105:e408\u2013e411","journal-title":"Haematologica"},{"key":"1186_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/ajcp\/aqaa116","volume":"154","author":"SE Gibson","year":"2020","unstructured":"Gibson\u00a0SE, Swerdlow\u00a0SH (2020) How I diagnose primary cutaneous marginal zone Lymphoma. Am J Clin Pathol 154:428\u2013449","journal-title":"Am J Clin Pathol"},{"key":"1186_CR11","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek\u00a0M, Cheson\u00a0BD, Catovsky\u00a0D et\u00a0al (2018) iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131:2745\u20132760","journal-title":"Blood"},{"key":"1186_CR12","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1182\/bloodadvances.2020002454","volume":"4","author":"PJ Hampel","year":"2020","unstructured":"Hampel\u00a0PJ, Cherng\u00a0HJ, Call\u00a0TG et\u00a0al (2020) Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib. Blood Adv 4:4508\u20134511","journal-title":"Blood Adv"},{"key":"1186_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","volume":"34","author":"E Hoster","year":"2016","unstructured":"Hoster\u00a0E, Rosenwald\u00a0A, Berger\u00a0F et al (2016) Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell Lymphoma: results from randomized trials of the European mantle cell Lymphoma network. J\u00a0Clin Oncol 34:1386\u20131394","journal-title":"J Clin Oncol"},{"key":"1186_CR14","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3324\/haematol.2009.013714","volume":"95","author":"G Kanellis","year":"2010","unstructured":"Kanellis\u00a0G, Mollejo\u00a0M, Montes-Moreno\u00a0S et al (2010) Splenic diffuse red pulp small B\u2011cell lymphoma: revision of a\u00a0series of cases reveals characteristic clinico-pathological features. Haematologica 95:1122\u20131129","journal-title":"Haematologica"},{"key":"1186_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","volume":"113","author":"T Katzenberger","year":"2009","unstructured":"Katzenberger\u00a0T, Kalla\u00a0J, Leich\u00a0E et al (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a\u00a0predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113:1053\u20131061","journal-title":"Blood"},{"key":"1186_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/annonc\/mdw185","volume":"27","author":"K Koch","year":"2016","unstructured":"Koch\u00a0K, Hoster\u00a0E, Ziepert\u00a0M et al (2016) Clinical, pathological and genetic features of follicular lymphoma grade 3A: a\u00a0joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Ann Oncol 27:1323\u20131329","journal-title":"Ann Oncol"},{"key":"1186_CR17","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","volume":"45","author":"C Laurent","year":"2021","unstructured":"Laurent\u00a0C, Adelaide\u00a0J, Guille\u00a0A et al (2021) High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B. Am J Surg Pathol 45:1324\u20131336","journal-title":"Am J Surg Pathol"},{"key":"1186_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/MPH.0b013e31820e4636","volume":"34","author":"MA Lones","year":"2012","unstructured":"Lones\u00a0MA, Raphael\u00a0M, Mccarthy\u00a0K et\u00a0al (2012) Primary follicular lymphoma of the testis in children and adolescents. J\u00a0Pediatr Hematol Oncol 34:68\u201371","journal-title":"J Pediatr Hematol Oncol"},{"key":"1186_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/17474086.2021.1908121","volume":"14","author":"E Matutes","year":"2021","unstructured":"Matutes\u00a0E (2021) Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021? Expert Rev Hematol 14:355\u2013363","journal-title":"Expert Rev Hematol"},{"key":"1186_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","volume":"94","author":"A Mozos","year":"2009","unstructured":"Mozos\u00a0A, Royo\u00a0C, Hartmann\u00a0E et al (2009) SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94:1555\u20131562","journal-title":"Haematologica"},{"key":"1186_CR21","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu\u00a0F, Martin-Garcia\u00a0D, Clot\u00a0G et al (2020) Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136:1419\u20131432","journal-title":"Blood"},{"key":"1186_CR22","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","volume":"4","author":"D Nann","year":"2020","unstructured":"Nann\u00a0D, Ramis-Zaldivar\u00a0JE, Muller\u00a0I et al (2020) Follicular lymphoma t(14;18)-negative is genetically a\u00a0heterogeneous disease. Blood Adv 4:5652\u20135665","journal-title":"Blood Adv"},{"key":"1186_CR23","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/cncr.28664","volume":"120","author":"CY Ok","year":"2014","unstructured":"Ok\u00a0CY, Xu-Monette\u00a0ZY, Tzankov\u00a0A et al (2014) Prevalence and clinical implications of cyclin D1 expression in diffuse large B\u2011cell lymphoma (DLBCL) treated with immunochemotherapy: a\u00a0report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer 120:1818\u20131829","journal-title":"Cancer"},{"key":"1186_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ctrv.2010.05.003","volume":"37","author":"T Robak","year":"2011","unstructured":"Robak\u00a0T (2011) Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment. Cancer Treat Rev 37:3\u201310","journal-title":"Cancer Treat Rev"},{"key":"1186_CR25","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMra2102568","volume":"386","author":"D Rossi","year":"2022","unstructured":"Rossi\u00a0D, Bertoni\u00a0F, Zucca\u00a0E (2022) Marginal-zone lymphomas. N\u00a0Engl J Med 386:568\u2013581","journal-title":"N Engl J Med"},{"key":"1186_CR26","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","volume":"121","author":"I Salaverria","year":"2013","unstructured":"Salaverria\u00a0I, Royo\u00a0C, Carvajal-Cuenca\u00a0A et al (2013) CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood 121:1394\u20131402","journal-title":"Blood"},{"key":"1186_CR27","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","volume":"6","author":"J Salmeron-Villalobos","year":"2022","unstructured":"Salmeron-Villalobos\u00a0J, Egan\u00a0C, Borgmann\u00a0V et al (2022) A unifying hypothesis for PNMZL and PTFL: morphological variants with a\u00a0common molecular profile. Blood Adv 6:4661\u20134674","journal-title":"Blood Adv"},{"key":"1186_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/modpathol.2016.51","volume":"29","author":"IN Siddiqi","year":"2016","unstructured":"Siddiqi\u00a0IN, Friedman\u00a0J, Barry-Holson\u00a0KQ et al (2016) Characterization of a\u00a0variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations. Mod Pathol 29:570\u2013581","journal-title":"Mod Pathol"},{"key":"1186_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3816\/CLM.2005.n.022","volume":"6","author":"P Solal-Celigny","year":"2005","unstructured":"Solal-Celigny\u00a0P (2005) Prognosis of follicular lymphomas. Clin Lymphoma 6:21\u201325","journal-title":"Clin Lymphoma"},{"key":"1186_CR30","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1200\/JCO.19.02314","volume":"38","author":"SP Treon","year":"2020","unstructured":"Treon\u00a0SP, Xu\u00a0L, Guerrera\u00a0ML et\u00a0al (2020) Genomic landscape of Waldenstrom macroglobulinemia and its impact on treatment strategies. J\u00a0Clin Oncol 38:1198\u20131208","journal-title":"J Clin Oncol"},{"key":"1186_CR31","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/ajh.25600","volume":"94","author":"M Varettoni","year":"2019","unstructured":"Varettoni\u00a0M, Boveri\u00a0E, Zibellini\u00a0S et\u00a0al (2019) Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: a multicentric study of the Rete Ematologica Lombarda (REL) network. Am J Hematol 94:1193\u20131199","journal-title":"Am J Hematol"},{"key":"1186_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","volume":"480","author":"V Vela","year":"2022","unstructured":"Vela\u00a0V, Juskevicius\u00a0D, Dirnhofer\u00a0S et al (2022) Mutational landscape of marginal zone B\u2011cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. Virchows Arch 480:403\u2013413","journal-title":"Virchows Arch"},{"key":"1186_CR33","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3324\/haematol.2019.243071","volume":"106","author":"L Wang","year":"2021","unstructured":"Wang\u00a0L, Tang\u00a0G, Medeiros\u00a0LJ et\u00a0al (2021) MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica 106:1381\u20131389","journal-title":"Haematologica"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01186-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01186-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01186-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T17:04:39Z","timestamp":1683219879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01186-5"}},"subtitle":["Neuigkeiten und offene Fragen","Novelties and open questions"],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01186-5","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,24]]},"assertion":[{"value":"1 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"I.\u00a0Anagnostopoulos und A.\u00a0Zam\u00f2 geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}